Better Therapeutics, Inc. (BTTX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -38.26 Million USD | -25.2% |
| 2021 | -30.56 Million USD | -383.31% |
| 2020 | -6.32 Million USD | -9.53% |
| 2019 | -5.77 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -5.34 Million USD | 23.97% |
| 2023 Q1 | -8.92 Million USD | -7.25% |
| 2023 Q2 | -7.02 Million USD | 21.29% |
| 2022 Q3 | -10.99 Million USD | -14.55% |
| 2022 Q2 | -9.59 Million USD | -2.72% |
| 2022 Q1 | -9.34 Million USD | 22.79% |
| 2022 FY | -38.26 Million USD | -25.2% |
| 2022 Q4 | -8.32 Million USD | 24.32% |
| 2021 FY | -30.56 Million USD | -383.31% |
| 2021 Q4 | -12.1 Million USD | -4935.07% |
| 2021 Q3 | -240.39 Thousand USD | 96.29% |
| 2021 Q2 | -6.47 Million USD | -116.74% |
| 2021 Q1 | -2.98 Million USD | -196672.07% |
| 2020 Q1 | -1380.00 USD | 0.0% |
| 2020 FY | -6.32 Million USD | -9.53% |
| 2020 Q4 | -1518.00 USD | 37.01% |
| 2020 Q3 | -2410.00 USD | 99.76% |
| 2020 Q2 | -1.01 Million USD | -73450.72% |
| 2019 FY | -5.77 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| America Great Health | -492.64 Thousand USD | -7666.663% |
| Ampio Pharmaceuticals, Inc. | -9.51 Million USD | -301.996% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -27.57% |
| Biora Therapeutics, Inc. | -67.14 Million USD | 43.014% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -141.507% |
| Calithera Biosciences, Inc. | -42.07 Million USD | 9.06% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -219.649% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -13.054% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -11.165% |
| Evelo Biosciences, Inc. | -108.46 Million USD | 64.724% |
| Evolutionary Genomics, Inc. | -2.01 Million USD | -1799.517% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -12.529% |
| Galera Therapeutics, Inc. | -46.95 Million USD | 18.507% |
| Innovation1 Biotech Inc. | -1.36 Million USD | -2698.186% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -91.892% |
| Molecular Templates, Inc. | -10.46 Million USD | -265.584% |
| Navidea Biopharmaceuticals, Inc. | -14.05 Million USD | -172.31% |
| NexImmune, Inc. | -29.19 Million USD | -31.068% |
| Orgenesis Inc. | -53.63 Million USD | 28.664% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | 25.406% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -48943.157% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -136.986% |
| Scopus BioPharma Inc. | -11.71 Million USD | -226.61% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 92.413% |
| Statera Biopharma, Inc. | -98.34 Million USD | 61.094% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -454.683% |
| Trevena, Inc. | -35.28 Million USD | -8.428% |
| Vaxxinity, Inc. | -58.28 Million USD | 34.354% |
| Vaccinex, Inc. | -22.88 Million USD | -67.192% |
| Vicapsys Life Sciences, Inc. | -1.04 Million USD | -3554.518% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | 24.522% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -426.806% |